A survey of methohexitone use by anesthetists in the clinical practice of ECT in Edinburgh

The Journal of ECT
A CookA I Scott

Abstract

The dosage of methohexitone (methohexital) administered by anesthetic staff was surveyed in a consecutive series of 52 patients referred for electroconvulsive therapy (ECT) in routine clinical practice in Edinburgh. Patients were weighed before the first treatment, and the ratio of administered dose to weight in kilograms calculated. Anesthesia was administered by three consultant staff and six nonconsultant staff. In only one patient (2%) was the administered dose within the range recommended by the Royal College of Psychiatrists (0.75-0.9 mg/kg), and in only four patients (8%) were the doses within the range recommended by the American Psychiatric Association (0.75-1.0 mg/kg). In all other patients the dose exceeded these recommended ranges; the average dose was 1.5 (+/- 0.3) mg/kg. The possible implications of these findings are discussed.

References

Sep 1, 1992·General Hospital Psychiatry·D P Devanand, H A Sackeim
May 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J Pippard
Jan 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A I Scott
Dec 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·J Pippard, L Ellam
May 15, 1995·Biological Psychiatry·C E CoffeyM Aque
Jun 1, 1993·Biological Psychiatry·W J RiddleG Fink
Jun 1, 1996·Anaesthesia·D LeeW Harrop-Griffiths
Sep 25, 1998·The British Journal of Psychiatry : the Journal of Mental Science·R Duffett, P Lelliott

❮ Previous
Next ❯

Citations

Feb 13, 2007·Der Anaesthesist·U Grundmann, M Oest
Apr 6, 2013·Der Anaesthesist·U Grundmann, S O Schneider
Jan 25, 2006·European Journal of Anaesthesiology·R HanssJ Scholz
Apr 26, 2002·Anesthesia and Analgesia·Zhengnian Ding, Paul F White
Dec 6, 2003·The Journal of ECT·Chadi A CalargeRobert P From
Jun 28, 2021·Journal of Anesthesia History·Susan Lava-ParmeleJames B Parmele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.